Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh M Jones

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Psychopharmacology|January 25, 2003
Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET studyRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
The American Journal of Psychiatry|August 6, 2003
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patientsRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Clinical effectiveness in first-episode patientsRuth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Biological Psychiatry|December 17, 2004
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging studyHugh M Jones, Michael J Brammer, Mary O'Toole, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Psychopharmacology|January 25, 2003
Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET studyRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
The American Journal of Psychiatry|August 6, 2003
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patientsRodrigo A Bressan, Kjell Erlandsson, Hugh M Jones, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Clinical effectiveness in first-episode patientsRuth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Biological Psychiatry|December 17, 2004
Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging studyHugh M Jones, Michael J Brammer, Mary O'Toole, et al.
Pageof 2